DURHAM, NC--(Marketwire - October 23, 2007) - Serenex, Inc., a leader in the discovery and development of small molecule Heat Shock Protein 90 (Hsp90) inhibitors, announced today that Dr. Richard Kent, chief executive officer, is scheduled to present at the Rodman & Renshaw 9th Annual Healthcare Conference taking place in New York at The Palace Hotel.
